BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27638840)

  • 21. Immunotherapy: last bullet in platinum refractory germ cell testicular cancer.
    Semaan A; Haddad FG; Eid R; Kourie HR; Nemr E
    Future Oncol; 2019 Feb; 15(5):533-541. PubMed ID: 30624089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.
    Ayers M; Lunceford J; Nebozhyn M; Murphy E; Loboda A; Kaufman DR; Albright A; Cheng JD; Kang SP; Shankaran V; Piha-Paul SA; Yearley J; Seiwert TY; Ribas A; McClanahan TK
    J Clin Invest; 2017 Aug; 127(8):2930-2940. PubMed ID: 28650338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
    Santagata S; Ligon KL; Hornick JL
    Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Tumour DNA for Monitoring Treatment Response to Anti-PD-1 Immunotherapy in Melanoma Patients.
    Ashida A; Sakaizawa K; Uhara H; Okuyama R
    Acta Derm Venereol; 2017 Nov; 97(10):1212-1218. PubMed ID: 28681063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current events in immunotherapy for upper aerodigestive tract cancer].
    Outh-Gauer S; Le Tourneau C; Broudin C; Scotte F; Roussel H; Hans S; Mandavit M; Tartour E; Badoual C
    Ann Pathol; 2017 Feb; 37(1):79-89. PubMed ID: 28111039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
    Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
    Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDX2 immunostaining in primary and metastatic germ cell tumours of the testis.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    J Int Med Res; 2016 Dec; 44(6):1323-1330. PubMed ID: 28322096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of microRNAs in the diagnosis and monitoring of pediatric germ cell tumors: Kazakh experience.
    Saliyeva S; Boranbayeva R; Bulegenova M; Beloussov V
    Pediatr Hematol Oncol; 2024; 41(2):121-134. PubMed ID: 37898912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tissue biomarkers of response to anti-PD-1 immunotherapies in melanoma].
    Adam J; Tomasic G; Robert C
    Ann Pathol; 2017 Feb; 37(1):55-60. PubMed ID: 28111041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
    Cao D; Li J; Guo CC; Allan RW; Humphrey PA
    Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the M371-Test Under Real-life Conditions for Diagnosis and Follow Up of Testicular Germ Cell Tumors.
    Pycha S; D'Elia C; Mian C; Schwienbacher C; Hanspeter E; Palermo M; Pycha A; Danuser H; Trenti E
    Anticancer Res; 2023 Apr; 43(4):1649-1653. PubMed ID: 36974797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Development of PD-1/PD-L1 Immunotherapy for Gastrointestinal Cancers: Facts and Hopes.
    Chau I
    Clin Cancer Res; 2017 Oct; 23(20):6002-6011. PubMed ID: 28615369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing.
    Ruf CG; Isbarn H; Wagner W; Fisch M; Matthies C; Dieckmann KP
    Urol Oncol; 2014 Jan; 32(1):33.e1-6. PubMed ID: 23395239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of immune checkpoint inhibition in platinum refractory germ-cell tumors.
    Zschäbitz S; Lasitschka F; Jäger D; Grüllich C
    Ann Oncol; 2016 Jul; 27(7):1356-60. PubMed ID: 27029705
    [No Abstract]   [Full Text] [Related]  

  • 36. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part II-The Challenge of Programmed Death Ligand-1 Testing and Its Role in Microsatellite Instability-High Colorectal Cancer.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):26-34. PubMed ID: 29120224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
    Danilova L; Wang H; Sunshine J; Kaunitz GJ; Cottrell TR; Xu H; Esandrio J; Anders RA; Cope L; Pardoll DM; Drake CG; Taube JM
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7769-E7777. PubMed ID: 27837027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts.
    Takami H; Elzawahry A; Mamatjan Y; Fukushima S; Fukuoka K; Suzuki T; Yanagisawa T; Matsushita Y; Nakamura T; Satomi K; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Tamura K; Maehara T; Sugiyama K; Yoshimoto K; Sakai K; Nonaka M; Asai A; Yokogami K; Takeshima H; Narita Y; Shibui S; Nakazato Y; Hama N; Totoki Y; Kato M; Shibata T; Nishikawa R; Matsutani M; Ichimura K
    Neuro Oncol; 2022 Aug; 24(8):1246-1258. PubMed ID: 35137206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune mechanisms and possible immune therapy in testicular germ cell tumours.
    Chovanec M; Mardiak J; Mego M
    Andrology; 2019 Jul; 7(4):479-486. PubMed ID: 31169364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety of anti-PD-1/PD-L1 antibodies for treatment of advanced or refractory cancers: a meta-analysis.
    Zhang T; Xie J; Arai S; Wang L; Shi X; Shi N; Ma F; Chen S; Huang L; Yang L; Ma W; Zhang B; Han W; Xia J; Chen H; Zhang Y
    Oncotarget; 2016 Nov; 7(45):73068-73079. PubMed ID: 27683031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.